|
|
|
|
LEADER |
00000ctm a2200000ua 4500 |
001 |
p731837 |
005 |
20240119160029.0 |
008 |
040218s2003 xx m 000 0 eng d |
035 |
|
|
|a (OCoLC)68184190
|
040 |
|
|
|a MPA
|c MPA
|d UtOrBLW
|
049 |
|
|
|a MPAA
|
090 |
|
|
|a M.S. Thesis
|
100 |
1 |
|
|a Omstead, Mary Nallin.
|
245 |
1 |
0 |
|a Thalidomide: dangerous drug or miracle cure? :
|b its impact on the FDA; weighing its potential for benefit and risk /
|c Mary Nallin Omstead.
|
264 |
|
0 |
|a [Place of publication not identified] :
|b [publisher not identified],
|c 2003.
|
300 |
|
|
|a v, 90 leaves ;
|c 30 cm
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
500 |
|
|
|a Graduate program in Drug Regulatory Affairs and Health Policy.
|
502 |
|
|
|a Thesis (M.S.)--Massachusetts College of Pharmacy and Health Sciences, 2003.
|
504 |
|
|
|a Includes bibliographic references.
|
610 |
1 |
0 |
|a United States.
|b Food and Drug Administration.
|0 n 80126147
|
650 |
|
0 |
|a Thalidomide
|x Law and legislation.
|0 sh 85134471
|
951 |
|
|
|a 731837
|
994 |
|
|
|a C0
|b MPA
|
999 |
f |
f |
|i 625c84b2-d25e-55ca-b6d9-d893f6e84329
|s b511e8b1-307a-5bda-b907-64eb3bc2d594
|t 0
|
952 |
f |
f |
|p Can circulate
|a Massachusetts College of Pharmacy and Health Sciences
|b Worcester Campus
|c MCPHS Worcester Library
|d Archives Thesis Collection
|t 0
|e M.S. Thesis 2003
|h Other scheme
|i Book
|m 0113401695631
|